Skip to content

BioLife Solutions BLFS Debt-to-assets

Debt-to-assets at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
0.4×0.0×
Danaher logo
DanaherDHR
0.2×0.0×
Azenta logo
AzentaAZTA
LeMaitre Vascular logo
LeMaitre VascularLMAT
0.0×
TEC
Bio-TechneTECH
0.1×0.0×
CryoPort, Inc. logo
CryoPort, Inc.CYRX
0.3×+0.2×

Other financials

Income statement

See full
Revenue$27.5M+24.7%
Gross profit$17.5M+18.2%
Operating income$27.0K+105%
Net income$1.2M+365%
EPS (diluted)$0.02

Balance sheet

See full
Cash & equivalents$22.8M-65.9%
Total debt$17.4M-35.6%
Total equity$372.2M+5.6%
Total assets$400.9M+1.5%

Cash flow

See full
Operating cash flow-$491.0K-128%
CapEx$167.0K-4.6%
Free cash flow-$658.0K-142%

Valuation

See full
Market cap$1.34B+33.1%
Enterprise value$1.34B+38.1%
P/S13.5×+0.6×

Profitability

See full
Gross margin66.9%
Operating margin-16.7%
Net margin-68.7%
FCF margin-15.9%+18.7pp

Returns & leverage

See full
Return on equity-14.5%-4.7pp
Debt / equity0.0×
Current ratio7.3×+2.6×

Where this comes from

Calculated from BioLife Solutions’s reported figures.

Based on the most recent quarter.

The official record: BioLife Solutions’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about BioLife Solutions's debt-to-assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is BioLife Solutions's debt-to-assets?
BioLife Solutions (BLFS) reported debt-to-assets of 0× in Q1 2026.
How has BioLife Solutions's debt-to-assets changed year-over-year?
BioLife Solutions's debt-to-assets decreased by 36.5% year-over-year, from 0.1× to 0×.
What is the long-term trend for BioLife Solutions's debt-to-assets?
Over 5 years (2020 to 2025), BioLife Solutions's debt-to-assets has grown at a -1.5% compound annual growth rate (CAGR), from 0× to 0×.
What does debt-to-assets mean?
Total debt divided by total assets at the quarter end. Measures the share of the asset base financed by debt.